Financial Results (Consolidated)

Billions of yen

Revenue

In the fiscal year ended March 31, 2019, the Group recorded ¥2,431.5 billion in consolidated revenue (down 0.1% from the previous fiscal year), reflecting such factors as a sales decrease in the document business, although sales increased in the medical systems business, bio CDMO business, regenerative medicine business and electronic materials business.

Income

Consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America.

 

 

Operating income largely increased to ¥209.8 billion (up 70.1% from the previous fiscal year) due to improved profitability and positive impacts of structural reforms in the document business.


 

Consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America.

Revenue

Operating Income

Income Before Income Taxes
　

Net Income Attributable to FUJIFILM Holdings

Net Income Attributable to FUJIFILM Holdings per Share

Consolidated Balance Sheets

Billions of yen
FY2015/3 FY2016/3 FY2017/3 FY2018/3 FY2019/3
Cash and cash equivalents 726.9 600.9 876.0 768.2 654.7
Notes and accounts receivable 656.2 643.6 635.8 619.1 617.8
Inventories 367.4 349.2 339.2 361.3 374.5
Other current assets 163.1 172.6 183.8 112.2 83.9
Total current assets 1,913.5 1,766.3 2,034.8 1,860.8 1,730.9
Property, plant and equipment 527.3 532.6 520.6 537.5 526.8
Goodwill, net 505.0 506.9 499.8 591.6 655.5
Investment securities and other 556.2 506.2 478.0 503.0 501.5
Total noncurrent assets 1,588.5 1,545.7 1,498.4 1,632.1 1,683.8
Total assets 3,502.0 3,312.0 3,533.2 3,492.9 3,414.7
Short-term and long-term debt 349.7 365.7 558.8 454.2 524.1
Notes and accounts payable 263.1 257.1 257.9 248.5 238.4
Other liabilities 471.0 457.2 448.4 491.5 407.3
Total liabilities 1,083.8 1,080.0 1,265.1 1,194.2 1,169.8
Total FUJIFILM Holdings shareholders' equity 2,195.5 2,014.8 2,043.6 2,079.1 2,037.0
Noncontrolling interests 222.6 217.2 224.5 219.6 207.9
Total equity 2,418.2 2,232.0 2,268.1 2,298.7 2,244.9
Total liabilities and equity 3,502.0 3,312.0 3,533.2 3,492.9 3,414.7

Cash Flows

Billions of yen
FY2015/3 FY2016/3 FY2017/3 FY2018/3 FY2019/3
Net income 126.6 133.5 147.2 144.2 157.1
Depreciation & amortization 126.4 125.0 117.6 127.6 129.9
Change in notes and accounts
receivable		 -4.4 -20.1 3.4 41.3 4.9
Change in inventories 10.9 5.8 4.9 -7.5 -12.3
Change in notes and accounts
payable-trade		 -20.5 1.7 5.7 -20.0 -12.5
Others 28.7 -22.4 9.8 -24.5 -17.8
C/F from operating activities 267.8 223.5 288.6 261.1 249.3
Capital expenditure -56.9 -63.8 -74.6 -63.0 -68.5
Purchases of software -26.6 -22.3 -22.3 -18.5 -20.5
Sales and purchases of marketable
and investment securities		 1.2 14.2 5.1 108.9 -24.4
Acquisitions of businesses - -36.7 -1.3 -127.3 -84.3
Others -42.3 -48.7 -23.3 -11.9 -10.9
C/F from investing activities -124.6 -157.3 -116.4 -111.8 -208.6
Free cash flows 143.2 66.2 172.2 149.3 40.7
Free cash flows without acquisitions of businesses and others 142.0 88.7 168.4 167.7 149.4

Caution

  • These data are prepared based on the financial results reports.

  • The frequency of updates may change in accordance with changes to the format of the financial results reports.

  • Please see the financial results reports and other materials for detailed information regarding the settlement of accounts.

  • The contents of these data will not immediately reflect corrections to the financial results reports when announced.

  • While we pay due caution to the conversion of data for the posting, please note that there is a possibility that errors may occur in the information due to uncontrollable circumstances, such as the unauthorized alteration of contents by a third party or mechanical defects resulting from equipment malfunction.

  • Service provided by Nomura Investor Relations Co., Ltd.

Powered by